Skip to main content
Varun Beverages Limited logo

Varun Beverages Limited — Investor Relations & Filings

Ticker · VBL ISIN · INE200M01039 LEI · 33580058NWEMWBDNMD48 BSE.NS Manufacturing
Open in API
Filings indexed 776 across all filing types
Latest filing 2025-02-04 Regulatory Filings
Country IN India
Listing BSE.NS VBL

About Varun Beverages Limited

https://www.varunbeverages.com

Varun Beverages Limited (VBL) is a major franchisee of PepsiCo, operating as one of the largest producers and distributors of PepsiCo products outside the United States. The company manages the end-to-end process of manufacturing, marketing, and distributing a diverse portfolio of beverages. This includes carbonated soft drinks, non-carbonated drinks, and packaged drinking water under prominent brands such as Pepsi, Seven-Up, Mirinda, Mountain Dew, Tropicana, Gatorade, Sting, and Aquafina. VBL maintains an extensive distribution infrastructure and large-scale production facilities to serve a broad consumer base across various international territories. Its business model is defined by a long-standing strategic partnership with PepsiCo, focusing on supply chain integration and market penetration to sustain its position in the global beverage market.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the schedule of upcoming investor meetings. It references Regulation 30 of the SEBI Listing Regulations, which pertains to disclosure obligations. The content is about informing the market of planned investor meetings and explicitly states that no unpublished price sensitive information will be shared. There are no financial statements, detailed financial data, or report attachments. The document length is only 2021 characters, indicating it is a brief announcement rather than a full report or transcript. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-02-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges about an upcoming investor meeting scheduled for February 11, 2025. It references compliance with SEBI Listing Regulations and provides details about the meeting participants and location. There is no financial data, no report attached or referenced as being published, and no detailed financial or management discussion. The document is an announcement of an investor meeting, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2025-02-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal announcement addressed to stock exchanges (NSE and BSE) regarding a scheduled conference call with investors and analysts. It references the discussion of financial results for the fourth quarter and the year ended December 31, 2024. The document includes details about the timing, dial-in numbers, and registration for the call. There is no actual financial data or detailed transcript included in the text; it is purely an announcement of the upcoming conference call event. According to the classification rules, such announcements about conference calls are best classified as Call Transcript (CT) only if the full transcript is provided. Since this is only an announcement of the call, it does not qualify as a transcript. It is also not a report publication announcement (RPA) because it does not mention a report being attached or published. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the conference call event, since it does not fit other categories and is not the transcript itself.
2025-02-03 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-02-03 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about an upcoming Board of Directors meeting to consider and approve audited financial results for the quarter and financial year ended December 31, 2024, and to consider a proposal for a final dividend recommendation. It also mentions the closure of the trading window in compliance with insider trading regulations. The document does not contain the financial results themselves but is an announcement of the meeting and related procedural information. The document length is short (2452 characters), and it serves as an intimation rather than the actual financial report or dividend declaration. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not contain the actual financial data or dividend details.
2025-02-03 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding an investment in the share capital of a subsidiary company. It details the subscription of shares in a subsidiary, including the amount invested, shareholding percentage, and background information about the subsidiary. The document is an announcement of a capital investment transaction by the company, not a full financial report or earnings release. It fits the category of Capital/Financing Update (CAP) as it provides an update on the company's financing activity related to capital investment in a subsidiary.
2025-01-02 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.